KDM5A, a H3K4-spesific KDM demethylase, was found to be implicated in developing drug resistance in a study on the epigenetic basis of cancer drug resistance [116], and it was enriched in lung cancer tissues as well as drug-resistant cells [117]. This evidence concerns the gene KDM5A and lung cancer.